Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Ovarian cancer
Closed
Phase 1/2
This study is for women who have a high grade (fast growing) cancer that has come back after previous treatment (recurrent cancer).
The study is for women who have:
These cancers are treated in the same way. So when we use the term ovarian cancer in this summary, we are referring to all 3.
Recruitment start: 1 August 2016
Recruitment end: 3 May 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr John Green
Aprea Therapeutics AB
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 31 May 2018
CRUK internal database number: 12753